1/77
Looks like no tags are added yet.
Antidepressant classes
Tricyclic antipsychotics, SSRI, SNRI, MAOI, noradrenergic and specific serotonergic antidepressants (NaSSA), SARI (serotonin antagonist and reuptake inhibitors
Tricyclic antidepressants
amitriptyline, imipramine
Tricyclic antidepressants MoA
Inhibit SERT and NET, increased serotonin and noradrenaline levels
SSRI drugs
Fluoxetine, paroxetine
SSRI MoA
Selective SERT inhibition
SNRI drugs
venlafaxine, duloxetine
SNRI MoA
SERT and NET inhibition
MAOI drug
Moclobemide, tranylcypromine
MAOI MoA
inhibit monoamine oxidase, monoamine neurotransmitter degredation
NaSSA drugs
Mirtazapine
NaSSA MoA
Block presynaptic a2 receptors —> increased Noradrenaline and 5-HT release
SARI drugs
Trazodone, Nefazodone
SARI MoA
5-HT2A antagonism + serotonin reuptake inhibition
5-HT3 antagonists
setrones
Setrone subclasses
carbazone derivates, indazoles, indole derivates, isoquinoline derivates
Setrone drugs
Ondasetrone, granisetron, tropisetron, palonosetron
Setron MoA
Competitive orthosteric antagonists of 5-HT3 ligand gated cation channel
—> prevention of serotonin-induced channel activation
—>antiemetic effect
Migraine drug classes
triptans, titans, gepants
Triptans drugs
sumatriptan, zolmitriptan, eletriptan
Triptans MoA
5-HTB1/D1 agonist—> vasoconstriction
Ditans drugs
Lasmiditan
ditans MoA
Selective 5-HT1F agonist —> inhibits trigeminal signalling and neuropeptide release, without clinically relevant vasoconstriction
Gepants drugs
ubrogepant, rimegepant, atogepant
Gepants MoA
CGRP receptor antagonist—> competitive
in migrain nerve terminals in the trigeminal vascular system release CGRP protein which binds to the receptor causing neurogenic inflammation, vasodilation and transmission of pain signals

Antiepileptic drug classes
Hydantions, Dibenzazepins(carbamazepine), Triazines, gabapentinoids, barbiturates
hydantoins drugs
phenytoin
Hydantoins MoA
stabilize inactivated voltage-gated Na+ channel
Common structural features of phenytoin, carbamazepine, lamotrigine
two benzene rings π–π interaction, Amine π-dipole interactions

Dibenzazepines drug
carbamazepine

Carbamazepine MoA
Triazines drug
Lamotrigine
Triazine MoA
Inbibits voltage-gates Na ´channels
Gabapentanoids drugs
Gabapentin, pregabalin
Gabapentanoids MoA
Bind α₂δ subunit of voltage hated Ca2+ channel, leads to decreased excitatory transmitter release glutamate, noradrenaline and substanse P
Barbiturates drugs
phenobarbital
Barbiturates MoA
positive allosteric GABA-A modulator, increases GABA mediated effects (excitatory neurotransmitter)
Important structures for drugs to interact with Na+ channel, epilepsy
Two aromatic rings and NH for polar interactions
Benzodiazepines MoA
GABA-A positive allosteric modulators → ↑ frequency of GABA-dependent Cl⁻ channel opening
Z-drug drugs, benzodiazepine like hypotics
Zollpidem, zaleplon
Z-drugs MoA
GABA-A positive allosteric modulators → ↑ frequency of GABA-dependent Cl⁻ channel opening

Which functional groups are important for SAR

Antiparkinsonian drug classes
Dopamine precursor, Peripheral DOPA decarboxylase inhibitors, Dopamine receptor agonist, MAO-B inhibitors, COMT inhibitors, Anticholinergics, NMDA antagonists

Dopamine precursor drugs
Levodopa
Levodopa MoA
Crosses the BBB and is converted into dopamine in CNS
Peripheral DOPA decarboxylase inhibitors drugs
Carbidopa, benserazinde
Carbidopa MoA
reduce peripheral conversion of Levodopa (levodopa to dopamine) increases the concentration which can reach to brain
NMDA antagonist drugs
Amantadine
NMDA antagonists MoA
Amantadine, Reduces NMDA mediated excitatory signalling, noncompetitive

Anticolinergics drugs
trihexyfenidyl, benzotropin, biberidine
Anticolinergic drug MoA
block central muscarinic receptors
which receptor antipsychotics effect
D2, neuroleptics
Antipsychotics classes
phenothiazine, haloperidol, atypical antipsychotics (clozapine,olanzapine), D2 partial agonist (aripiprazole)
Haloperidol MoA
potent D2 antagonism
Atypical antipsychotics drugs and MoA
Clozapine, olanzapine. multireceptor effect, particularly 5-HTsA and D2 antagonism
Aripiprazole MoA
D2 partial agonism, with serotonin receptor activity
Antibiotic groups 11
aminoglycoside, glycopeptides, lipopeptides, macrolides, Azalides (azithromycin), ketolides, tetracyclines, glycylcycline, polypeptides, polymyxins,
Aminoglycosides drug and MoA
streptomycin, gentamycin, tobramycin, kanamycin
—> Bind 30S ribosome, translation errros
Glycopeptides drugs and MoA
Vancomycin, teicoplanin
—> bind D-ala-D-ala of cell wall precursors and inhibit peptidoglycan synthesis
lipopeptides durgs and MoA
Daptomycin, Ca2+ dependent membrane binding and disruption of membrane function
Macrolides drugs and MoA
erythromycin, clarithromycin, roxithromycin
—> bind 50A ribosome, inhibit protein elongation
Azithromycin MoA
50S inhibition, protein elongation
ketolides drugs and MoA
Telithromycin
—> 50s inhibition, protein elongation
tetracyclines drug and MoA
oxytetracycline, doxycycline
—> bind 30S and block aminoacyl-tRNA binding

polypeptides drug and MoA
bacitracin
—> blocks recycling of bactoprenol carrier in cell wall synthesis
polymyxins drug and MoA
polymyxin B, polymyxin E (colistin)
—> binds lipoplysaccaharides adn disturbs gram-negative outer membrane
Antifungal classes 4
polyene macrolides, eichinocandins, azoles, allylamines
Polyene macrolides drugs and MoA
Amphotericin B, nystatin
—> bind ergosterol and disrupt fungal membrane
eichinocandins drug and MoA
Caspofungin, micafungin, anidulafungin -fungin
—>Inhibit β-1,3-glucan synthase → impaired fungal cell wall
azoles drugs and MoA
fluconazole, intraconazole
—> inhibit fungal CYP51, decreased ergosterol synthesis
allylamines drug and MoA
terbinafine
—> inhibit squalene epoxidase, enzyme in ergosterol synthesis
influenza antiviral classes
neuramidase inhibitors, Cap-dependent endonuclease inhibitorsne
neuramidase inhib. drugs and MoA
oseltamivir, zanamivir
SIALIC ACID MIMETICS
→ inhibit neuraminidase (surface enzyme) This prevents newly replicated viruses from cleaving from host cells, stopping the spread of the virus throughout the respiratory tract
ACE drugs and MoA
enalapril, captopril, -pril
—> inhibit ACE, reduced angiotensin II leads to vasodilation
β-blockers drugs and MoA
propanolol, metoprolol, bisoprolol
—> Antagonize beta-adrenoceptors, decreased heart rate and cardiac workload
Antiviral mechanisms
entry inhibition, fusion inhibition, nucleoside and nucleotide analogs, non-nucleotide reverse transcript inhibitors, integrate inhibitors, protease inhibitors, neuraminidase inhibitors
integrase inhibition mechanism
blocs integration of HIV DNA into the host genome
protease inhibitors
ritonavir, prevent cleacage of HIV poly proteins —> immature noninfectious virions
neuraminidase inhibitors
competitive inhibition of influenza neuraminidase—> prevent release go new visions
Neuraminidase normally cleaves terminal sialic acids, newly formed virions remain attached or aggregate, reducing viral spread